New Treatment Options for Refractory/Resistant CMV Infection

Despite advances in monitoring and treatment, cytomegalovirus (CMV) infections remain one of the most common complications after solid organ transplantation (SOT). CMV infection may fail to respond to standard first- and second-line antiviral therapies with or without the presence of antiviral resis...

Descripció completa

Dades bibliogràfiques

Autors principals:	Carla Simone Walti, Nina Khanna, Robin K. Avery, Ilkka Helanterä
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-10-01
Col·lecció:	Transplant International
Matèries:	cytomegalovirus antiviral resistance antiviral therapy letermovir maribavir virus-specific adoptive T cell therapy
Accés en línia:	https://www.frontierspartnerships.org/articles/10.3389/ti.2023.11785/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!